Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP913235.RAbsVghUtVo7duqmsan9OXxw8ouv8iNgbrD-gS_sXPAfg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP913235.RAbsVghUtVo7duqmsan9OXxw8ouv8iNgbrD-gS_sXPAfg130_assertion type Assertion NP913235.RAbsVghUtVo7duqmsan9OXxw8ouv8iNgbrD-gS_sXPAfg130_head.
- NP913235.RAbsVghUtVo7duqmsan9OXxw8ouv8iNgbrD-gS_sXPAfg130_assertion description "[Although CD9 was detected in the epithelium of normal prostatic tissues, reduced or loss of CD9 expression within neoplastic cells was observed in 24% of 107 clinically localized primary adenocarcinomas, 85% of 60 clinically advanced primary adenocarcinomas, 85% of 65 lymph node metastases, and 65% of 23 bone metastases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913235.RAbsVghUtVo7duqmsan9OXxw8ouv8iNgbrD-gS_sXPAfg130_provenance.
- NP913235.RAbsVghUtVo7duqmsan9OXxw8ouv8iNgbrD-gS_sXPAfg130_assertion evidence source_evidence_literature NP913235.RAbsVghUtVo7duqmsan9OXxw8ouv8iNgbrD-gS_sXPAfg130_provenance.
- NP913235.RAbsVghUtVo7duqmsan9OXxw8ouv8iNgbrD-gS_sXPAfg130_assertion SIO_000772 17406028 NP913235.RAbsVghUtVo7duqmsan9OXxw8ouv8iNgbrD-gS_sXPAfg130_provenance.
- NP913235.RAbsVghUtVo7duqmsan9OXxw8ouv8iNgbrD-gS_sXPAfg130_assertion wasDerivedFrom befree-20140225 NP913235.RAbsVghUtVo7duqmsan9OXxw8ouv8iNgbrD-gS_sXPAfg130_provenance.
- NP913235.RAbsVghUtVo7duqmsan9OXxw8ouv8iNgbrD-gS_sXPAfg130_assertion wasGeneratedBy ECO_0000203 NP913235.RAbsVghUtVo7duqmsan9OXxw8ouv8iNgbrD-gS_sXPAfg130_provenance.